Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.
Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy, CEO of mTuitive.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice
Webinar presenters Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
June 2016—BioTek Instruments launched the Lionheart FX Automated Live Cell Imager with Augmented Microscopy. Lionheart FX is optimized for kinetic live cell imaging, with up to 100× air and oil immersion magnification in a variety of slides, dishes, microplates, and flasks.
June 2016—Eurofins Scientific has acquired PerkinElmer’s U.S. prenatal screening laboratory services business, PerkinElmer Labs/NTD.
June 2016—MedTest announced the availability of a 25-OH Vitamin D Assay for the BS-480 chemistry analyzer. MedTest is the exclusive U.S. distributor of the BS-480 analyzer including manufacturing and distribution of reagents, calibrators, and quality control products for the general chemistry and drugs of abuse testing markets in the United States and Canada.
June 2016—BD Biosciences introduced the BD Accuri C6 Plus flow cytometer. This new cytometer has several optimized enhancements to the internal hardware, fluidics, and software while maintaining the core elements of the prior platform such as the nonpressurized peristaltic pump system and compact exterior design.
June 2016—MDxHealth announced the commercial launch of its SelectMDx for Prostate Cancer test in the U.S. as a laboratory developed test. Testing will be conducted at MDxHealth’s CAP- and CLIA-accredited laboratory facilities in Irvine, Calif.
June 2016—HTG Molecular Diagnostics entered into a research collaboration agreement with Bristol-Myers Squibb to evaluate the potential for immuno-oncology molecular profiling in multiple tumor types.
June 2016—The AIA-900 Benchtop model is now available from Tosoh. The AIA-900 uses Tosoh’s Unit Dose Test Cup reagent technology. Single, unitized test cups do not require premixing, premeasuring, or onboard refrigeration. The AIA-Pack test cup format works with every Tosoh AIA automated immunoassay system. Reagents are interchangeable, so laboratories with more than one Tosoh system can use the same reagents.
June 2016—SeraCare Life Sciences launched an expanded product line to support NGS-based somatic tumor profiling assay development, validation, and QC performance monitoring. The eight new Seraseq Solid Tumor Mutation Mix-II products contain 40 somatic variants with increases in the number of insertion-deletion mutations from four to 13 to challenge both the sequencing and variant calling algorithms.
June 2016—On May 4 Siemens Healthcare unveiled its new name, Siemens Healthineers. According to a company statement, the name “embodies the company’s pioneering spirit and engineering expertise in the healthcare industry.”
June 2016—Thermo Fisher Scientific received 510(k) clearance for two new EliA IgG tests for detecting anti-thyroglobulin and anti-thyroid peroxidase autoantibodies in serum or plasma. The CLIA-moderate laboratory tests are performed on the fully automated Phadia 250, 2500, and 5000 laboratory systems.
